Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3766342014 | Hydrocortisone acetate 2.75 microgram/mg and lidocaine hydrochloride 50 microgram/mg cutaneous ointment | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3766343016 | Product containing precisely hydrocortisone acetate 2.75 microgram/1 milligram and lidocaine hydrochloride 50 microgram/1 milligram conventional release cutaneous ointment (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 4597640015 | Hydrocortisone acetate 2.75 mg/g and lidocaine hydrochloride 50 mg/g cutaneous ointment | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 4597645013 | Product containing precisely hydrocortisone acetate 2.75 milligram/1 gram and lidocaine hydrochloride 50 milligram/1 gram conventional release cutaneous ointment (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely hydrocortisone acetate 2.75 milligram/1 gram and lidocaine hydrochloride 50 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has precise active ingredient | Lidocaine hydrochloride | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely hydrocortisone acetate 2.75 milligram/1 gram and lidocaine hydrochloride 50 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Is a | Product containing only hydrocortisone and lidocaine in cutaneous dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 2.75 milligram/1 gram and lidocaine hydrochloride 50 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has basis of strength substance | Hydrocortisone acetate | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely hydrocortisone acetate 2.75 milligram/1 gram and lidocaine hydrochloride 50 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has concentration strength numerator unit | microgram | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely hydrocortisone acetate 2.75 milligram/1 gram and lidocaine hydrochloride 50 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely hydrocortisone acetate 2.75 milligram/1 gram and lidocaine hydrochloride 50 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has concentration strength numerator value | 2.75 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely hydrocortisone acetate 2.75 milligram/1 gram and lidocaine hydrochloride 50 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has concentration strength numerator value | 50 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely hydrocortisone acetate 2.75 milligram/1 gram and lidocaine hydrochloride 50 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has concentration strength numerator unit | microgram | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely hydrocortisone acetate 2.75 milligram/1 gram and lidocaine hydrochloride 50 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely hydrocortisone acetate 2.75 milligram/1 gram and lidocaine hydrochloride 50 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has concentration strength denominator unit | milligram | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely hydrocortisone acetate 2.75 milligram/1 gram and lidocaine hydrochloride 50 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has basis of strength substance | Lidocaine hydrochloride | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely hydrocortisone acetate 2.75 milligram/1 gram and lidocaine hydrochloride 50 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 2.75 milligram/1 gram and lidocaine hydrochloride 50 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has concentration strength denominator unit | milligram | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely hydrocortisone acetate 2.75 milligram/1 gram and lidocaine hydrochloride 50 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has precise active ingredient | Hydrocortisone acetate | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely hydrocortisone acetate 2.75 milligram/1 gram and lidocaine hydrochloride 50 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has manufactured dose form | Conventional release cutaneous ointment | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 2.75 milligram/1 gram and lidocaine hydrochloride 50 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely hydrocortisone acetate 2.75 milligram/1 gram and lidocaine hydrochloride 50 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has concentration strength denominator unit | gram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely hydrocortisone acetate 2.75 milligram/1 gram and lidocaine hydrochloride 50 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely hydrocortisone acetate 2.75 milligram/1 gram and lidocaine hydrochloride 50 milligram/1 gram conventional release cutaneous ointment (clinical drug) | Has concentration strength denominator unit | gram | true | Inferred relationship | Existential restriction modifier | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR